Circulating tumor DNA for diagnosis, prognosis and treatment of gastrointestinal malignancies

Minimally invasive detection of circulating tumor DNA (ctDNA) in peripheral blood or other body fluids of patients with gastrointestinal malignancies via liquid biopsy has emerged as a promising biomarker. This is urgently needed, as conventional imaging and plasma protein-derived biomarkers lack se...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirchweger, Patrick, Wundsam, Helwig Valentin, Rumpold, Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244970/
https://www.ncbi.nlm.nih.gov/pubmed/35949436
http://dx.doi.org/10.5306/wjco.v13.i6.473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244970/
https://www.ncbi.nlm.nih.gov/pubmed/35949436
http://dx.doi.org/10.5306/wjco.v13.i6.473

Ejemplares similares